About the Authors
- Manu De Rycker
-
* E-mail: m.derycker@dundee.ac.uk (MDR); d.w.gray@dundee.ac.uk (DWG)
Affiliation Drug Discovery Unit, Division of Biological Chemistry and Drug Discovery, University of Dundee, Dundee, United Kingdom
- John Thomas
-
Affiliation Drug Discovery Unit, Division of Biological Chemistry and Drug Discovery, University of Dundee, Dundee, United Kingdom
- Jennifer Riley
-
Affiliation Drug Discovery Unit, Division of Biological Chemistry and Drug Discovery, University of Dundee, Dundee, United Kingdom
- Stephen J. Brough
-
Affiliation GlaxoSmithKline, Biological Sciences, Medicines Research Centre, Stevenage, Hertfordshire, United Kingdom
- Tim J. Miles
-
Affiliation GlaxoSmithKline, Diseases of the Developing World, Parque Tecnologico de Madrid, Servero Ochoa, Madrid, Spain
- David W. Gray
-
* E-mail: m.derycker@dundee.ac.uk (MDR); d.w.gray@dundee.ac.uk (DWG)
Affiliation Drug Discovery Unit, Division of Biological Chemistry and Drug Discovery, University of Dundee, Dundee, United Kingdom
Competing Interests
TM and SB are employed by GlaxoSmithKline. MDR, JT, JR and DWG have no competing interests to declare.
Author Contributions
Conceived and designed the experiments: MDR JT JR SJB TJM DWG. Performed the experiments: MDR JT JR SJB. Analyzed the data: MDR JT JR SJB TJM DWG. Wrote the paper: MDR TJM DWG.